(*5*)
Here are the most vital information, tendencies and evaluation that traders want to begin their buying and selling day:
1. Stock futures flat as traders take care of a flood of earnings
Traders work on the flooring of the New York Stock Exchange (NYSE) in New York City, U.S., October 20, 2021.
Brendan McDermid | Reuters
2. Microsoft, Alphabet report better-than-expected outcomes
Satya Nadella, chief government officer of Microsoft Corp.
David Paul Morris | Bloomberg | Getty Images
Alphabet CEO Sundar Pichai gestures during a session at the World Economic Forum (WEF) annual meeting in Davos, on January 22, 2020.
Fabrice COFFRINI | AFP | Getty Images
Alphabet shares were under modest pressure in premarket trading. The Google parent reported late Tuesday third-quarter earnings and revenue that exceeded estimates. However, YouTube ad revenue and Google’s cloud revenue were below estimates.
3. Robinhood shares sink as crypto trading slows
4. FDA panel recommends Covid shots for younger kids
Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on October 01, 2021 in San Rafael, California.
Justin Sullivan | Getty Images
A key Food and Drug Administration advisory committee has recommended a lower dose of Pfizer’s Covid vaccine for kids ages 5 to 11, a critical step in getting some 28 million more children in the U.S. protected against the virus as the delta variant spreads. Signoff from the full FDA and the Centers for Disease Control and Prevention, which could happened in days, is needed for shots to begin.
Medicine pills are seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland in October 2021.
Jakub Porzycki | NurPhoto | Getty Images
Merck has signed a licensing agreement with a U.N.-backed public health organization that will enable affordable global access for molnupiravir, the U.S. drugmaker’s promising oral antiviral capsule to deal with Covid. Molnupiravir was invented at Emory University and licensed to Ridgeback Biotherapeutics, which partnered with Merck.
5. Democrats unveil billionaires’ tax to assist pay for Biden agenda
The U.S. Capitol, photographed on Tuesday, Sept. 28, 2021 in Washington, DC.
Kent Nishimura | Los Angeles Times | Getty Images
— The Associated Press contributed to this report. Follow all the market motion like a professional on CNBC Pro. Get the newest on the pandemic with CNBC’s coronavirus protection.
